sulfadiazine has been researched along with Deglutition Disorders in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Deglutition Disorders: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are infrequent mucocutaneous diseases, rapidly progressive and life-threatening." | 1.72 | Odynophagia as the first manifestation of toxic epidermal necrolysis. ( Guallart Domenech, F; Martínez Ruiz de Apodaca, P; Ortega Beltrá, N; Pons Rocher, F, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ortega Beltrá, N | 3 |
| Guallart Domenech, F | 3 |
| Martínez Ruiz de Apodaca, P | 3 |
| Pons Rocher, F | 3 |
| Holtkamp, M | 1 |
| Okuducu, AF | 1 |
| Klingebiel, R | 1 |
| Ploner, CJ | 1 |
2 other studies available for sulfadiazine and Deglutition Disorders
| Article | Year |
|---|---|
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Odynophagia as the first manifestation of toxic epidermal necrolysis.
Topics: Acute Disease; Deglutition Disorders; Humans; Male; Pain; Stevens-Johnson Syndrome; Sulfadiazine | 2022 |
Cerebral toxoplasmosis in a patient with common variable immunodeficiency.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Brain; Central N | 2004 |